Blog and Topics

<Blog 2>Key considerations for unlocking Japan’s full cell & gene therapy and regenerative medicine potential

<Blog 1>Japan: A Unique Opportunity for Regenerative Medicine and Cell & Gene Therapy

◆Interview : BioPharma APAC "Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate CGT Access Between Japan and Australia"

Exhibition Report : INTERPHEX Week TOKYO2025 / Regenerative Medicine EXPO

Teijin Regenet, TOHO HOLDINGS and ITOCHU Corp. Enter into Business Alliance Aimed at Building Novel Regenerative Medicine Ecosystem

◆ Exhibition / Seminar Information ◆

The Kashiwanoha Regenerative Medicine Platform Website is now open

<Blog 5>How to maximize chances of success when expanding your CGT&RM portfolio into Japan

<Blog 4>Choosing Japan for your CGT&RM portfolio expansion: What are your options for manufacture?